[
  {
    "ts": null,
    "headline": "These Stocks Are Moving the Most Today: Nvidia, Oracle, Alphabet, Strategy, Intuit, Lilly, Gap, Elastic, Veeva, and More",
    "summary": "Stocks rallied Friday after the previous session’s selloff driven by concerns about bloated artificial-intelligence valuations.  Nvidia  rose 1.2%.  Nvidia’s report and better-than-expected guidance gave the market a solid read on artificial-intelligence demand but failed to reassure investors who have been fretting about where the money is coming from and whether it will be well spent.",
    "url": "https://finnhub.io/api/news?id=5d1e44a203ab4e9afcf2970b15d02a3d09268a9534511b31ea710920be3107e1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763752200,
      "headline": "These Stocks Are Moving the Most Today: Nvidia, Oracle, Alphabet, Strategy, Intuit, Lilly, Gap, Elastic, Veeva, and More",
      "id": 137571827,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Stocks rallied Friday after the previous session’s selloff driven by concerns about bloated artificial-intelligence valuations.  Nvidia  rose 1.2%.  Nvidia’s report and better-than-expected guidance gave the market a solid read on artificial-intelligence demand but failed to reassure investors who have been fretting about where the money is coming from and whether it will be well spent.",
      "url": "https://finnhub.io/api/news?id=5d1e44a203ab4e9afcf2970b15d02a3d09268a9534511b31ea710920be3107e1"
    }
  },
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Gain Friday Afternoon",
    "summary": "Health care stocks were higher Friday afternoon, with the NYSE Health Care Index rising 2.5% and the",
    "url": "https://finnhub.io/api/news?id=53028a7771df3c7886f5aa4a8601fd86c254e1bc84046f4bf74b5af72d478b5c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763750320,
      "headline": "Sector Update: Health Care Stocks Gain Friday Afternoon",
      "id": 137571996,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Health care stocks were higher Friday afternoon, with the NYSE Health Care Index rising 2.5% and the",
      "url": "https://finnhub.io/api/news?id=53028a7771df3c7886f5aa4a8601fd86c254e1bc84046f4bf74b5af72d478b5c"
    }
  },
  {
    "ts": null,
    "headline": "Lilly first drugmaker to hit trillion-dollar club on weight-loss demand",
    "summary": "STORY: Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter an exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.A more than 35% rally in the company's stock this year has largely been driven by the explosive growth of the weight-loss drug market.Novo Nordisk had the early lead in the space, but Lilly's drugs - Mounjaro and Zepbound - have surged in popularity and helped eclipse its rival in prescriptions.Friday's record high put Lilly's stock price at more than $1,060 a share, giving it one of the richest valuations in big pharma - about 50 times its anticipated earnings over the next 12 months, according to LSEG data.Since the launch of Zepbound in late 2023, Lilly's stock has gained more than 75%, compared with an over 50% rise in the S&P 500 during the same period.Wall Street estimates the overall weight-loss drug market to be worth $150 billion by 2030, with Lilly and Novo together controlling the majority of projected global sales.",
    "url": "https://finnhub.io/api/news?id=e48832bdd2ebd42719738940f1aa352d1348bfe3a085723aa341b4d0fc6ccfc6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763750008,
      "headline": "Lilly first drugmaker to hit trillion-dollar club on weight-loss demand",
      "id": 137571997,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "STORY: Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter an exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.A more than 35% rally in the company's stock this year has largely been driven by the explosive growth of the weight-loss drug market.Novo Nordisk had the early lead in the space, but Lilly's drugs - Mounjaro and Zepbound - have surged in popularity and helped eclipse its rival in prescriptions.Friday's record high put Lilly's stock price at more than $1,060 a share, giving it one of the richest valuations in big pharma - about 50 times its anticipated earnings over the next 12 months, according to LSEG data.Since the launch of Zepbound in late 2023, Lilly's stock has gained more than 75%, compared with an over 50% rise in the S&P 500 during the same period.Wall Street estimates the overall weight-loss drug market to be worth $150 billion by 2030, with Lilly and Novo together controlling the majority of projected global sales.",
      "url": "https://finnhub.io/api/news?id=e48832bdd2ebd42719738940f1aa352d1348bfe3a085723aa341b4d0fc6ccfc6"
    }
  },
  {
    "ts": null,
    "headline": "AI Stocks Are Taking a Beating. What to Buy Instead.",
    "summary": "November has been NO-vember when it comes to tech stocks.  Investors are shunning artificial-intelligence leaders and other momentum names.  Investors seem to be embracing drug stocks, insurers, and medical equipment companies again.",
    "url": "https://finnhub.io/api/news?id=f2d2488c4c6f2ed92243dfc42d4748a6447d88ce8c106bb2fbf041c884c1f4e0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763748780,
      "headline": "AI Stocks Are Taking a Beating. What to Buy Instead.",
      "id": 137571833,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "November has been NO-vember when it comes to tech stocks.  Investors are shunning artificial-intelligence leaders and other momentum names.  Investors seem to be embracing drug stocks, insurers, and medical equipment companies again.",
      "url": "https://finnhub.io/api/news?id=f2d2488c4c6f2ed92243dfc42d4748a6447d88ce8c106bb2fbf041c884c1f4e0"
    }
  },
  {
    "ts": null,
    "headline": "Weight-loss drug boom propels Eli Lilly to $1 trillion",
    "summary": "Eli Lilly became the first healthcare company to enter into the $1 trillion market-cap club on Friday",
    "url": "https://finnhub.io/api/news?id=5357c17f645a8056651be1fa01581bac2c6715e6320c482aaf2d54fb56ddb9e1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763748125,
      "headline": "Weight-loss drug boom propels Eli Lilly to $1 trillion",
      "id": 137571835,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly became the first healthcare company to enter into the $1 trillion market-cap club on Friday",
      "url": "https://finnhub.io/api/news?id=5357c17f645a8056651be1fa01581bac2c6715e6320c482aaf2d54fb56ddb9e1"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly becomes first pharma group to join $1tn club",
    "summary": "Eli Lilly’s weight-loss drugs have made it the first pharma company to hit a $1tn market valuation, a sharp turnaround from this summer when...",
    "url": "https://finnhub.io/api/news?id=3d4515f31120c053dfc167f646cb05008f610776c50ff5b9bfe8ac457732a3e3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763747605,
      "headline": "Eli Lilly becomes first pharma group to join $1tn club",
      "id": 137571981,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly’s weight-loss drugs have made it the first pharma company to hit a $1tn market valuation, a sharp turnaround from this summer when...",
      "url": "https://finnhub.io/api/news?id=3d4515f31120c053dfc167f646cb05008f610776c50ff5b9bfe8ac457732a3e3"
    }
  },
  {
    "ts": null,
    "headline": "Lilly Breaks $1 Trillion Mark In Historic Milestone",
    "summary": "Investors reward LLY's GLP-1 strength while Novo struggles",
    "url": "https://finnhub.io/api/news?id=ec9b687567fec03308bfef858ad14261041396c4ce5b84b8abd4019b195edd4d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763747258,
      "headline": "Lilly Breaks $1 Trillion Mark In Historic Milestone",
      "id": 137572001,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Investors reward LLY's GLP-1 strength while Novo struggles",
      "url": "https://finnhub.io/api/news?id=ec9b687567fec03308bfef858ad14261041396c4ce5b84b8abd4019b195edd4d"
    }
  },
  {
    "ts": null,
    "headline": "The $1 Trillion Drug Bet: How Eli Lilly Outsprinted Big Tech on Fat, Pills, and Wall Street Dreams",
    "summary": "Lilly just leapfrogged pharma history--and it's not done. A $40B pill could push it toward $1.4T next.",
    "url": "https://finnhub.io/api/news?id=c1185ebb271da714d456d936ab28101d8ec4ed097b689eb20697af264090e7f2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763747248,
      "headline": "The $1 Trillion Drug Bet: How Eli Lilly Outsprinted Big Tech on Fat, Pills, and Wall Street Dreams",
      "id": 137572002,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Lilly just leapfrogged pharma history--and it's not done. A $40B pill could push it toward $1.4T next.",
      "url": "https://finnhub.io/api/news?id=c1185ebb271da714d456d936ab28101d8ec4ed097b689eb20697af264090e7f2"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly Becomes First Pharma To Join $1 Trillion Club Alongside Nvidia, Apple, Others",
    "summary": "Eli Lilly on Friday became the first health care company to top $1 trillion in market capitalization, joining a club of mostly tech names.",
    "url": "https://finnhub.io/api/news?id=41114c11d38c1ee69c312ef07f5cd7cebd082e7204316ffdf05aa15da531d38b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763745399,
      "headline": "Eli Lilly Becomes First Pharma To Join $1 Trillion Club Alongside Nvidia, Apple, Others",
      "id": 137571851,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly on Friday became the first health care company to top $1 trillion in market capitalization, joining a club of mostly tech names.",
      "url": "https://finnhub.io/api/news?id=41114c11d38c1ee69c312ef07f5cd7cebd082e7204316ffdf05aa15da531d38b"
    }
  },
  {
    "ts": null,
    "headline": "Stocks to Watch Friday: Eli Lilly, Intuit, Gap, Warner Bros.",
    "summary": "↗️ Eli Lilly (LLY): The drugmaker became the first pharmaceutical company to hit a $1 trillion market capitalization. Booming demand for its weight-loss drugs has boosted shares. ↗️ Intuit (INTU): The financial technology company's quarterly results topped forecasts, boosted by AI demand from mid-size businesses.",
    "url": "https://finnhub.io/api/news?id=15ed9344bd9d7de3abeda7b7fbbdc5c1945b14d392a686980b5e076d50e189d8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763744221,
      "headline": "Stocks to Watch Friday: Eli Lilly, Intuit, Gap, Warner Bros.",
      "id": 137572004,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "↗️ Eli Lilly (LLY): The drugmaker became the first pharmaceutical company to hit a $1 trillion market capitalization. Booming demand for its weight-loss drugs has boosted shares. ↗️ Intuit (INTU): The financial technology company's quarterly results topped forecasts, boosted by AI demand from mid-size businesses.",
      "url": "https://finnhub.io/api/news?id=15ed9344bd9d7de3abeda7b7fbbdc5c1945b14d392a686980b5e076d50e189d8"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly Stock Joins the $1 Trillion Club as LLY Hits New All-Time Highs",
    "summary": "Eli Lilly (LLY) just became the first healthcare company to join the $1 trillion market cap club. Shares are trading at a new all-time high on Friday, Nov. 21. The stock is up 40% in the past year and nearly 80% in the past two years. Analysts remain highly confident,...",
    "url": "https://finnhub.io/api/news?id=cc2230288afffb539cf3a0c62a0064b8a2b3bc74dc732c28fada6a2af7887ca8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763743803,
      "headline": "Eli Lilly Stock Joins the $1 Trillion Club as LLY Hits New All-Time Highs",
      "id": 137572005,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly (LLY) just became the first healthcare company to join the $1 trillion market cap club. Shares are trading at a new all-time high on Friday, Nov. 21. The stock is up 40% in the past year and nearly 80% in the past two years. Analysts remain highly confident,...",
      "url": "https://finnhub.io/api/news?id=cc2230288afffb539cf3a0c62a0064b8a2b3bc74dc732c28fada6a2af7887ca8"
    }
  },
  {
    "ts": null,
    "headline": "Top Midday Stories: Lilly Becomes First Pharma Company to Hit $1 Trillion Market Cap; Enviri to Sell Clean Earth to Veolia for $3.04 Billion",
    "summary": "The major US stock indexes were up in late-morning trading Friday as investors remained concerned ov",
    "url": "https://finnhub.io/api/news?id=e7b46b9cdf0d29ac7bc6b9f43aad0e7ca325027c051dbf462c4726f75990fd23",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763743795,
      "headline": "Top Midday Stories: Lilly Becomes First Pharma Company to Hit $1 Trillion Market Cap; Enviri to Sell Clean Earth to Veolia for $3.04 Billion",
      "id": 137572006,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The major US stock indexes were up in late-morning trading Friday as investors remained concerned ov",
      "url": "https://finnhub.io/api/news?id=e7b46b9cdf0d29ac7bc6b9f43aad0e7ca325027c051dbf462c4726f75990fd23"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly reaches $1 trillion market value for first time",
    "summary": "Weight-loss and diabetes drugs drive historic milestone",
    "url": "https://finnhub.io/api/news?id=cc6ec2a2f38ff978c5627a2b9522df9a6d552a29428fe768118931b910197dc0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763742766,
      "headline": "Eli Lilly reaches $1 trillion market value for first time",
      "id": 137572007,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Weight-loss and diabetes drugs drive historic milestone",
      "url": "https://finnhub.io/api/news?id=cc6ec2a2f38ff978c5627a2b9522df9a6d552a29428fe768118931b910197dc0"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly’s Market Cap Breaks $1 Trillion After Climbing $400 Billion in 3 Months",
    "summary": "It’s the only drug company ever to have a $1 trillion capitalization value; the other U.S. companies are tech giants and Berkshire Hathaway.",
    "url": "https://finnhub.io/api/news?id=de0b601da5816ca59bc340b293549022346ee71301eaead7b522e59bd28e1db5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763742540,
      "headline": "Eli Lilly’s Market Cap Breaks $1 Trillion After Climbing $400 Billion in 3 Months",
      "id": 137572008,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "It’s the only drug company ever to have a $1 trillion capitalization value; the other U.S. companies are tech giants and Berkshire Hathaway.",
      "url": "https://finnhub.io/api/news?id=de0b601da5816ca59bc340b293549022346ee71301eaead7b522e59bd28e1db5"
    }
  },
  {
    "ts": null,
    "headline": "BJ's beats on earnings, Ross lifts outlook, Eli Lilly hits $1T",
    "summary": "Market Catalysts host Julie Hyman tracks several of Friday's top trending stock tickers, including Eli Lilly (LLY), BJ's Wholesale Club (BJ), and Ross Stores (ROST). To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.",
    "url": "https://finnhub.io/api/news?id=aea7bddbc57d027462631fb55c33bb292585c0a28469ecdea27d5ca6f3a04026",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763740393,
      "headline": "BJ's beats on earnings, Ross lifts outlook, Eli Lilly hits $1T",
      "id": 137572009,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Market Catalysts host Julie Hyman tracks several of Friday's top trending stock tickers, including Eli Lilly (LLY), BJ's Wholesale Club (BJ), and Ross Stores (ROST). To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.",
      "url": "https://finnhub.io/api/news?id=aea7bddbc57d027462631fb55c33bb292585c0a28469ecdea27d5ca6f3a04026"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly joins $1 trillion club as weight-loss drugs fuel growth",
    "summary": "Investing.com -- Eli Lilly reached $1 trillion in market value on Friday, with shares briefly touching an all-time high of $1,060, and becoming the first pharmaceutical company to ever achieve this milestone.",
    "url": "https://finnhub.io/api/news?id=cdb0d500601b354bf8f4d4351addc73427c8c6612b289ad588892c27e64a24a5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763739015,
      "headline": "Eli Lilly joins $1 trillion club as weight-loss drugs fuel growth",
      "id": 137572010,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Investing.com -- Eli Lilly reached $1 trillion in market value on Friday, with shares briefly touching an all-time high of $1,060, and becoming the first pharmaceutical company to ever achieve this milestone.",
      "url": "https://finnhub.io/api/news?id=cdb0d500601b354bf8f4d4351addc73427c8c6612b289ad588892c27e64a24a5"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly Reaches $1 Trillion Market Cap on Booming Weight-Loss Drugs",
    "summary": "Lilly becomes the first pharmaceutical company to hit that threshold, joining a select club of mostly tech companies.",
    "url": "https://finnhub.io/api/news?id=ba40fafec26f3c4239546b0eb983d3058db6f4cdeaddf9857baf524acf5bc67a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763738940,
      "headline": "Eli Lilly Reaches $1 Trillion Market Cap on Booming Weight-Loss Drugs",
      "id": 137571857,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Lilly becomes the first pharmaceutical company to hit that threshold, joining a select club of mostly tech companies.",
      "url": "https://finnhub.io/api/news?id=ba40fafec26f3c4239546b0eb983d3058db6f4cdeaddf9857baf524acf5bc67a"
    }
  },
  {
    "ts": null,
    "headline": "Healthcare ETFs to Buy as Big Pharma Rapidly Integrates AI",
    "summary": "LLY's expanding AI alliances highlight how pharma-tech partnerships are transforming healthcare and lifting key sector ETFs like XLV.",
    "url": "https://finnhub.io/api/news?id=f4f5567a3ba6747522fe9272e3686fcdc1b0c7fef74e048e2a49bcf1bbbc9336",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763738340,
      "headline": "Healthcare ETFs to Buy as Big Pharma Rapidly Integrates AI",
      "id": 137571876,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "LLY's expanding AI alliances highlight how pharma-tech partnerships are transforming healthcare and lifting key sector ETFs like XLV.",
      "url": "https://finnhub.io/api/news?id=f4f5567a3ba6747522fe9272e3686fcdc1b0c7fef74e048e2a49bcf1bbbc9336"
    }
  },
  {
    "ts": null,
    "headline": "This Month's Stock Trend Hasn't Been AI. Here's What's Been Climbing Instead",
    "summary": "Healthcare stocks have outperformed the broader market by nearly 10 percentage points this month as AI bubble concerns have weighed on tech stocks.",
    "url": "https://finnhub.io/api/news?id=aeb9f425345bd2c5b14be30c17961db77f7d63f64a9cceb66a8893c1fdc0b773",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763738158,
      "headline": "This Month's Stock Trend Hasn't Been AI. Here's What's Been Climbing Instead",
      "id": 137572013,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Healthcare stocks have outperformed the broader market by nearly 10 percentage points this month as AI bubble concerns have weighed on tech stocks.",
      "url": "https://finnhub.io/api/news?id=aeb9f425345bd2c5b14be30c17961db77f7d63f64a9cceb66a8893c1fdc0b773"
    }
  },
  {
    "ts": null,
    "headline": "Here's Why Eli Lilly (LLY) is a Strong Momentum Stock",
    "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",
    "url": "https://finnhub.io/api/news?id=18c083b646220da31596a1e2b0879a47f6cdff1d084712ae8e3a833d286e16fe",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763736602,
      "headline": "Here's Why Eli Lilly (LLY) is a Strong Momentum Stock",
      "id": 137572014,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",
      "url": "https://finnhub.io/api/news?id=18c083b646220da31596a1e2b0879a47f6cdff1d084712ae8e3a833d286e16fe"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly: I Trimmed My Position By 50% After A 39% Gain (Rating Downgrade)",
    "summary": "Discover a portfolio update with insights on Eli Lilly, MP Materials, and Meta. Learn why these investment moves could boost returns.",
    "url": "https://finnhub.io/api/news?id=267abba03329726cbda3e031cdfae2ddd3b340e810b750dbf3d0563549bd86a7",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763726761,
      "headline": "Eli Lilly: I Trimmed My Position By 50% After A 39% Gain (Rating Downgrade)",
      "id": 137570039,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2224431015/image_2224431015.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Discover a portfolio update with insights on Eli Lilly, MP Materials, and Meta. Learn why these investment moves could boost returns.",
      "url": "https://finnhub.io/api/news?id=267abba03329726cbda3e031cdfae2ddd3b340e810b750dbf3d0563549bd86a7"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly hits $1 trillion market value, a first for a health-care company",
    "summary": "The pharmaceutical giant Eli Lilly's stock has been riding the skyrocketing demand for its weight loss injection Zepbound and diabetes treatment Mounjaro.",
    "url": "https://finnhub.io/api/news?id=109642ba6b3309fa0006a9afd858dd08900330a1df25478c5e1e91995636ee77",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763719579,
      "headline": "Eli Lilly hits $1 trillion market value, a first for a health-care company",
      "id": 137570110,
      "image": "https://image.cnbcfm.com/api/v1/image/107388672-1710764847941-gettyimages-2092473213-dsc01895copy_8zcnfedn.jpeg?v=1761820877&w=1920&h=1080",
      "related": "LLY",
      "source": "CNBC",
      "summary": "The pharmaceutical giant Eli Lilly's stock has been riding the skyrocketing demand for its weight loss injection Zepbound and diabetes treatment Mounjaro. ",
      "url": "https://finnhub.io/api/news?id=109642ba6b3309fa0006a9afd858dd08900330a1df25478c5e1e91995636ee77"
    }
  },
  {
    "ts": null,
    "headline": "Evaluating Eli Lilly Shares After 30% Surge Driven by Obesity Drug Pipeline News",
    "summary": "Curious whether Eli Lilly’s stock is still a smart buy after its rapid rise? Let’s break down the numbers and see if the current price matches up with real value. Shares have vaulted higher lately, climbing 30.5% in just the last month and notching a stunning 40.2% gain over the past year. Investors are watching Eli Lilly closely after headline-making developments in its obesity and diabetes drug pipeline sent the stock to new highs. This reflects excitement over blockbuster potential and...",
    "url": "https://finnhub.io/api/news?id=4eff3266b6106701c5619e9a4dce7a63bc2fdf4e862c8ff653a5540b711aa34f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763684415,
      "headline": "Evaluating Eli Lilly Shares After 30% Surge Driven by Obesity Drug Pipeline News",
      "id": 137566486,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Curious whether Eli Lilly’s stock is still a smart buy after its rapid rise? Let’s break down the numbers and see if the current price matches up with real value. Shares have vaulted higher lately, climbing 30.5% in just the last month and notching a stunning 40.2% gain over the past year. Investors are watching Eli Lilly closely after headline-making developments in its obesity and diabetes drug pipeline sent the stock to new highs. This reflects excitement over blockbuster potential and...",
      "url": "https://finnhub.io/api/news?id=4eff3266b6106701c5619e9a4dce7a63bc2fdf4e862c8ff653a5540b711aa34f"
    }
  },
  {
    "ts": null,
    "headline": "Analysts get more bullish on this non-tech stock",
    "summary": "The market has been swinging recently, with the S&P 500 index down 1.5% and the Nasdaq Composite down more than 2% over the past month. Investors are now questioning whether the tech momentum can continue. Some non-tech stocks have performed well, and Eli Lilly (LLY) is one of them. Eli ...",
    "url": "https://finnhub.io/api/news?id=e7a16505fab8c33d656dd04f6c60a173ad4a8cc26cdc8a1b0a149c539b1eb7ae",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763683308,
      "headline": "Analysts get more bullish on this non-tech stock",
      "id": 137566487,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The market has been swinging recently, with the S&P 500 index down 1.5% and the Nasdaq Composite down more than 2% over the past month. Investors are now questioning whether the tech momentum can continue. Some non-tech stocks have performed well, and Eli Lilly (LLY) is one of them. Eli ...",
      "url": "https://finnhub.io/api/news?id=e7a16505fab8c33d656dd04f6c60a173ad4a8cc26cdc8a1b0a149c539b1eb7ae"
    }
  }
]